Aberrant expression of costimulatory molecules in splenocytes of the mevalonate kinase-deficient mouse model of human hyper-IgD syndrome (HIDS)

Journal of Inherited Metabolic Disease

Volumn 35, Issue 1, 2012, Pages 159-168

  Hager, Elizabeth J ^a,d   Piganelli, Jon D ^b   Tse, Hubert M ^c   Gibson, K Michael ^a  

^a MICHIGAN TECHNOLOGICAL UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c University of Alabama at Birmingham   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN; CONCANAVALIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCOPROTEIN P 15095; INTERLEUKIN 2 RECEPTOR ALPHA; MEVALONATE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE LOCATION; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; IMMUNOPATHOGENESIS; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HETEROZYGOTE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; MALE; MEVALONATE KINASE DEFICIENCY; MICE; MUTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SEX FACTORS; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863327928     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-011-9349-x     Document Type: Article

References (37)

1. Allen M, Canadian Academic Detailing Corporation (2006) Statins in primary prevention: uncertainty in women, elderly. Am Fam Physician 73:973-974
2. Baharaki D, Dueymes M, Perrichot R, Basset C, Le Corre R, Cledes J, Youinou P (1996) Aberrant glycosylation of IgA from patients with IgA nephropathy. Glycoconj J 13:505-511
3. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Sharpe AH, Vallera DA (1999) Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells. J Immunol 162:6368-6377
4. Butscher WG, Powers C, Olive M, Vinson C, Gardner K (1998) Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2. J Biol Chem 273:552-560
5. Chen C, Nabavi N (1994) In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1:147-154
6. Chui D, Sellakumar G, Green R, Sutton-Smith M, McQuistan T, Marek K, Morris H, Dell A, Marth J (2001) Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci USA 98:1142-1147
7. Cuthbert JA, Lipsky PE (1990) Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation. J Biol Chem 265:18568-18575
8. Davis SJ, Ikemizu S, Collins AV, Fennelly JA, Harlos K, Jones EY, Stuart DI (2001) Crystallization and functional analysis of a soluble deglycosylated form of the human costimulatory molecule B7-1. Acta Crystallogr D Biol Crystallogr 57:605-608
9. Ferrario CM (2008) Of gender, statins, and coronary artery interventions. Ther Adv Cardiovasc Dis 2:73-74
10. Fife BT, Bluestone JA (2008) Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 224:166-182
11. Freeman GJ, Borriello F, Hodes RJ, Reiser H, Gribben JJ, Ng JW, Kim J, Goldberg JM, Hathcock KGL, Lombard LA, Wang S, Gray G, Nadler LM, Sharpe AH (1993) Murine B7-2, and alternative CTLA-4 counter-receptor that costimulates T cell proliferation and interleukin-2 production. J Exp Med 178:2185-2192
12. Goldfinger S (2009) The inherited autoinflammatory syndrome: a decade of discovery. Trans Am Clin Climatol Assoc 120:413-418
13. Greenfield EA, Howard E, Paradis T, Nguyen K, Benazzo F, McLean P, Höllsberg P, Davis G, Hafler DA, Sharpe AH, Freeman GJ, Kuchroo VK (1997) B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors. J Immunol 158:2025-2034
14. Greenwald RJ, Freeman GJ, Sharpe AH (2005) The B7 family revisited. Annu Rev Immunol 23:515-548
15. Hager EJ, Tse HM, Piganelli JD, Gupta M, Baetscher M, Tse TE, Pappu AS, Steiner RD, Hoffmann GF, Gibson KM (2007) Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome. J Inherit Metab Dis 30:888-895
16. Hara Y, Kitazawa Y, Funeshima N, Kawasaki M, Sato Y, Tezuka K, Kimura H, Hatakeyama K, Li XK (2006) Anergic lymphocytes generated by blocking CD28 and ICOS pathways in vitro prolong rat cardiac graft survival. Int Immunopharmacol 6:1143-1151
17. Hiki Y, Kokubo T, Iwase H, Masaki Y, Sano T, Tanaka A, Toma K, Hotta K, Kobayashi Y (1999) Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 10:760-769
18. Ip WK, Wong CK, Leung TF, Lam CW (2006) Plasma concentrations of soluble CTLA-4, CD28, CD80 and CD86 costimulatory molecules reflect disease severity of acute asthma in children. Pediatr Pulmonol 41:674-682
19. Jenkins MK, Taylor PS, Norton SD, Urdahl KB (1991) CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol 147:2461-2466
20. Kearney ER, Pape KA, Loh DY, Jenkins MK (1994) Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327-339
21. Keir ME, Sharpe AH (2005) The B7/CD28 costimulatory family in autoimmunity. Immunol Rev 204:128-143
22. Kim YC, Kim KK, Shevach EM (2010) Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factorbeta signal transduction. Immunology 130(4):489-493
23. Krummel MF, Allison JP (1996) CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183:2533-2540
24. Li R, Perez N, Karumuthil-Melethil S, Prabhakar BS, Holterman MJ, Vasu C (2007) Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25 TGFbeta1+ adaptive regulatory T cells. J Immunol 179:5191-5203
25. Lohr J, Knoechel B, Jiang S, Sharpe AH, Abbas AK (2003) The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat Immunol 4:664-669
26. Mantha AJ, Hanson JE, Goss G, Lagarde AE, Lorimer IA, Dimitroulakos J (2005) Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor. Clin Cancer Res 11:2398-2407
27. Manzotti CN, Tipping H, Perry LC, Mead KI, Blair PJ, Zheng Y, Sansom DM (2002) Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells. Eur J Immunol 32:2888-2896
28. McAdam AJ, Chang TT, Lumelsky AE, Greenfield EA, Boussiotis VA, Duke-Cohan JS, Chernova T, Malenkovich N, Jabs C, Kuchroo VK, Ling V, Collins M, Sharpe AH, Freeman GJ (2000) Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J Immunol 165:5035-5040
29. Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Hammartröm L, Nonoyama S, Ochs HD, Puck J, Roifman C, Seger R, Wedgwood J (2009) Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 124:1161-1178
30. Perez N, Karumuthil-Melethil S, Li R, Prabhakar BS, Holterman MJ, Vasu C (2008) Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation. J Immunol 180:6566-6576
31. Perkins D, Wang Z, Donovan C, He H, Mark D, Guan G, Wang Y, Walunas T, Bluestone J, Listman J, Finn PW (1996) Regulation of CTLA4 expression during T cell activation. J Immunol 32:366-373
32. Salomon B, Bluestone JA (2001) Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19:225-252
33. Sethna MP, van Parijs L, Sharpe AH, Abbas AK, Freeman GJ (1994) A negative regulatory function of B7 revealed in B7-1 transgenic mice. Immunity 1:415-421
34. Taylor PA, Lees CJ, Fournier S, Allison JP, Sharpe AH, Blazar BR (2004) B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J Immunol 172:34-39
35. Vasu C, Prabhakar BS, Holterman MJ (2004) Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo) antigen specificity. J Immunol 173:2866-2876
36. Wentworth JM, Naselli G, Brown WA et al. (2010) Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 59(7):1648-1656
37. Wong CK, Lit LC, Tam LS, Li EK, Lam CW (2005) Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology 44:989-994